Malignant Otitis Externa Outcomes: A Study of the University HealthSystem Consortium Database

被引:39
作者
Hatch, Jonathan L. [1 ]
Bauschard, Michael J. [1 ]
Nguyen, Shaun A. [1 ]
Lambert, Paul R. [1 ]
Meyer, Ted A. [1 ]
McRackan, Theodore R. [1 ]
机构
[1] Med Univ South Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA
关键词
osteomyelitis; malignant otitis externa; miscellaneous; necrotizing otitis externa; cranial nerve paralysis; morbidity; BASE OSTEOMYELITIS; PROGNOSIS; PATTERNS;
D O I
10.1177/0003489418778056
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To characterize factors that affect outcomes for patients with malignant otitis externa (MOE). Methods: Retrospective review of inpatients with MOE was performed. Patient demographics, comorbid conditions, complications, procedures, and mortalities were analyzed. Results: A total of 786 patients with MOE were identified. The mean hospitalization length of stay (LOS) was 18.6 days (SD = 19.7). The overall mortality rate was 2.5% (n = 20), and complication rate was 4.3% (n = 34). Increasing age significantly and positively correlated with the incidence of MOE (r = 0.979, P < .0001). Factors that were associated with an increased rate of mortality were sepsis (odds ratio [OR] = 18.5; ES = 0.94; 95% CI, 0.47-1.42), congestive heart failure (OR = 3.1; ES = 0.42; 95% CI, 0.02-0.82), weight loss (OR = 10.2; ES = 1.23; 95% CI, 0.61-1.85), and coagulopathy (OR = 8.8; ES = 1.84; 95% CI, 0.91-2.77). Surgical intervention was performed in 19.2% (n = 151) of patients. Facial nerve involvement was present in 15.5% (n = 122) of patients and was associated with a significantly longer LOS of 12.9 days (SD = 19.6; ES = 0.21; 95% CI, 0.03-0.41). Conclusions: This large multi-institutional database study of MOE demonstrates that several patient factors impact the LOS and mortality. Patients at risk for unfavorable outcomes include the elderly, male gender, comorbidities, or cranial nerve involvement.
引用
收藏
页码:514 / 520
页数:7
相关论文
共 30 条
[1]   Malignant otitis externa: case series [J].
Ali, T. ;
Meade, K. ;
Anari, S. ;
ElBadawey, M. R. ;
Zammit-Maempel, I. .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2010, 124 (08) :846-851
[2]  
BAYARDELLE P, 1982, CAN MED ASSOC J, V126, P155
[3]   Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa [J].
Berenholz, L ;
Katzenell, U ;
Harell, M .
LARYNGOSCOPE, 2002, 112 (09) :1619-1622
[4]   The role of the otorhinolaryngologist in the management of central skull base osteomyelitis [J].
Cavel, Oren ;
Fliss, Dan M. ;
Segev, Yoram ;
Zik, Daniel ;
Khafif, Avi ;
Landsberg, Roee .
AMERICAN JOURNAL OF RHINOLOGY, 2007, 21 (03) :281-285
[5]   MALIGNANT EXTERNAL OTITIS [J].
CHANDLER, JR .
LARYNGOSCOPE, 1968, 78 (08) :1257-&
[6]   Necrotising (malignant) otitis externa in the UK: a growing problem. Review of five cases and analysis of national Hospital Episode Statistics trends [J].
Chawdhary, G. ;
Liow, N. ;
Democratis, J. ;
Whiteside, O. .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2015, 129 (06) :600-603
[7]   Comorbidity measures for use with administrative data [J].
Elixhauser, A ;
Steiner, C ;
Harris, DR ;
Coffey, RN .
MEDICAL CARE, 1998, 36 (01) :8-27
[8]   Necrotizing external otitis: A report of 46 cases [J].
Franco-Vidal, Valerie ;
Blanchet, Harold ;
Bebear, Cecile ;
Dutronc, Herve ;
Darrouzet, Vincent .
OTOLOGY & NEUROTOLOGY, 2007, 28 (06) :771-773
[9]   The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations [J].
Grandis, JR ;
Branstetter, BF ;
Yu, VL .
LANCET INFECTIOUS DISEASES, 2004, 4 (01) :34-39
[10]  
Guerrero-Espejo A, 2017, ACTA OTORRINOLAR ESP, V68, P23, DOI 10.1016/j.otorri.2016.02.010